Robinson Pharma Expands Costa Mesa, California, Operations
According to company officials, this new addition brings Robinson Pharma to now six buildings and totaling over 650,000 square feet. The new state-of-the-art eco-friendly facility will serve as RPI’s newest expansion to accommodate its continuing business growth.
The building spans 100,276 square feet and sits on more than five acres of land. RPI has committed to invest $20M in this facility to better serve its customers with the latest advances in nutraceutical contract manufacturing and quality assurance.
With these new investments, RPI said it will keep pace with the growing demand for wellness products and continue in its vision to provide the best in service in the supplement industry.
Robinson Pharma, Inc., is a Southern California-based full-service contract manufacturer of dietary supplements with over 650,000 square feet of production capabilities of capsules, softgels, tablets, powders, and liquids. Robinson Pharma, Inc. possesses multiple third-party certifications of current Good Manufacturing Practice (cGMP) and Safe Quality Food (SQF) compliance from well-reputed organizations, such as Eurofins, NPA, NSF, and UL for supplement manufacturing in the United States.
French-Based Advanced Accelerator Applications Plans Cancer Drug Production Campus in Indianapolis, Indiana
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Finding Talent in a Time of Economic Change
Mid-size Markets Competing for Business and Winning
Hitting the Reset Button: How to Pivot the Perception of Economic Development
Innovation in America Reaches New Heights
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019